Blue Steens in March 2020
Check out my latest monthly review! It summarises Blue Steens’ latest posts and showcases some informative online content that I haven’t released elsewhere. Click to read >>>
Glimpse at the complexity of drug prices
I feel that there is considerable confusion about drug prices amongst industry outsiders. Until I started looking into the topic, I had no idea how complex it was.
My MSc dissertation on healthcare derivatives
In 2019, I graduated with Distinction from the roller-coaster that was my one-year full-time MSc in Finance and Investment Management at the University of Aberdeen, Scotland.
Economics to boost antibiotics development
Considering the importance of antibiotics for our healthcare, the issue of a dwindling development pipeline must be addressed. This article outlines various economic suggestions.
Will bonding curves be researchers’ best friends?
Continuous token bonding curves, formerly referred to as curation markets, describe a blockchain framework that is different from the concept underlying the now widely known cryptocurrency Bitcoin.
Paying for patient expertise
Scientists in academic or other institutions use the unique insights patients provide to inform their research. Pharmaceutical companies oftentimes look for customer input primarily in late development stages. So far however, their main focus has been on […]